VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
EMA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
EMAEmera Incorporated
$51.51$15.6B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEMABalance Sheet

Emera Incorporated (EMA) Balance Sheet

27Y historyFree accessUpdated daily

Debt-to-equity rose to 1.54 in 2026Q2 from 1.49 in 2024Q4, with total debt up $2.3B, while the current ratio fell to 0.73, indicating tighter liquidity and increasing leverage.

EMA Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Total Assets34.55B44.78B42.95B39.48B39.74B34.24B31.23B24.56B32.31B28.77B29.22B12.01B9.84B8.88B7.53B6.92B6.33B5.29B5.27B4.17B4.06B4B3.94B3.84B3.91B3.96B2.95B2.9B
Asset Growth %0.79%4.26%8.79%-0.66%16.06%9.64%27.2%-24.01%12.31%-1.54%143.26%22.02%10.9%17.93%8.72%9.39%19.57%0.45%26.28%2.78%1.59%1.38%2.62%-1.71%-1.3%34.17%1.72%-
PP&E (Net)20.32B27.43B26.17B24.38B23B20.35B19.6B14.06B18.71B17B17.29B6.19B5.61B5.33B4.49B4.29B3.78B3.15B3.48B2.93B2.88B2.83B2.78B2.73B2.86B2.89B2.37B2.36B
PP&E / Total Assets %58.82%61.26%60.93%61.74%57.86%59.44%62.74%57.25%57.91%59.07%59.17%51.51%56.99%60.02%59.66%62.03%59.78%59.58%65.97%70.2%70.99%70.74%70.48%71.2%73.28%73.02%80.45%81.42%
Total Current Assets4.73B4.39B3.69B3.71B4.9B3.14B2.18B1.92B2.83B2.53B2.51B2.6B1.46B1.16B931M993.3M782.5M721.6M681.8M570M502.1M391.5M329.5M297.2M331.7M334.4M196.6M151.7M
Cash & Equivalents1.78B364.7M196M567M310M394M220M210.53M273M438M404M1.07B221.1M100.8M25.4M76.9M9.4M21.8M12.2M26.4M7.6M21.5M42.7M16.9M28.5M23M5.7M2.7M
Receivables1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Inventory579.45M820.33M781M790M769M538M453M360.13M474M418M472M314.3M294.5M245.8M177.6M198.8M177.8M174.5M131.2M99.7M113.6M76.1M73.4M89.8M108.7M152.9M85.8M82.4M
Other Current Assets941.78M1.15B1.42B1.08B2.06B1.07B621M415.65M862M532M598M316.9M379.4M240M117.1M185.5M78.7M90M128.5M98.1M127.3M25.3M13.9M7.6M38.2M27.5M4.6M600K
Long-Term Investments3.41B1.25B654M1.4B1.42B1.38B1.35B1.4B1.32B1.22B995M1.27B1.1B813.4M678.4M769.3M774.1M742.6M333.8M000000000
Goodwill4.08B5.58B5.86B5.87B6.01B5.7B5.72B4.5B6.31B5.8B6.21B264.1M221.5M206.5M193.5M197.7M178.9M87.6M102M287.9M253.6M246.9M000000
Intangible Assets00000000000191.9M134.3M118.4M114.2M100.7M103.5M92.1M0000178.5M182.9M156.3M131M100.5M66M
Other Assets4.28B5.72B6.19B3.92B4.18B3.38B2.39B2.53B2.97B2.09B2.09B1.47B1.28B1.18B1.09B535.1M693.5M491M658M590.7M578.7M680.8M726.2M693.9M574.8M595.3M373.2M380.4M
Total Liabilities24.34B31.4B29.66B27.39B28.3B24.09B22B17.92B23.96B21.59B22.41B7.68B6.14B5.98B5.25B5.1B4.53B3.76B3.68B2.81B2.39B2.37B2.34B2.27B2.31B2.51B1.72B1.73B
Total Debt17.22B21.62B19.81B19.8B19.04B16.4B15.41B12.17B16.6B15.12B15.71B4.77B4.01B4.13B3.71B3.52B3.25B2.73B2.45B1.83B1.79B1.87B1.87B1.89B1.94B2.14B1.56B1.59B
Net Debt15.45B21.25B19.61B19.23B18.73B16.01B15.19B11.96B16.32B14.68B15.31B3.69B3.79B4.03B3.68B3.44B3.24B2.71B2.44B1.8B1.79B1.85B1.83B1.87B1.91B2.12B1.55B1.59B
Long-Term Debt15.25B18.49B18.17B17.69B15.74B14.2B12.34B10.55B14.29B13.14B14.28B3.75B3.66B3.36B3.2B3.27B3.01B2.32B2.16B1.6B1.65B1.63B1.63B1.59B1.42B1.38B1.16B1.26B
Short-Term Borrowings1.98B3.01B1.63B2.11B3.3B2.2B3.01B1.58B2.31B1.98B1.44B1.02B352.1M766.3M457.5M246M240.8M409.7M289.3M225.6M136.6M241M246.2M295.5M519.2M760.5M402.2M328.5M
Capital Lease Obligations118.9M118.9M000063M47.04M-3.1B0-2.27B00-501.5M1M-676.6M2.6M7.3M0000000000
Total Current Liabilities4.44B6.62B5.12B4.54B7.29B4.88B4.88B3.21B4.55B3.95B3.72B2.08B1.15B1.53B999M801.7M690.3M810.1M880.1M585.8M501.8M506.4M488.7M505.9M697.6M938.9M567.2M464.7M
Accounts Payable1.2B1.95B1.99B1.45B2.02B1.49B1.15B862.16M1.29B1.16B1.24B394M370.7M382.6M294.8M332.9M293.9M305.9M307.1M282.7M286M248.6M233.4M214.1M175.1M175.1M136.4M133M
Accrued Expenses21.98M21.98M295M279M271M232M241M16.97M287M41M58M7M7.5M9.4M9.8M107M00071.3M65.2M13.6M10.8M7.4M000200K
Deferred Revenue0000000015M265M326M206.8M222.7M182.8M137.1M21.6M10.2M11M11.1M000000-760.5M-402.2M-328.3M
Other Current Liabilities1.26B1.64B1.18B689M1.67B945M476M757.28M666M762M987M654.5M358.8M335.5M231.3M99.1M41.5M85.2M275.8M000000000
Deferred Taxes9.16B1000K1000K1000K1000K1000K01000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K0
Other Liabilities2.77B3.65B4.04B2.81B3.07B3.15B4.72B3.12B686M1.63B467M1.06B1.36B36.8M19.9M119.5M300.9M422.1M-2.27B-1.68B149.4M-1.71B-1.71B-1.68B-1.5B-1.47B-1.16B-1.26B
Total Equity10.21B13.39B13.29B12.09B11.44B10.15B9.24B6.63B8.36B7.18B6.82B4.33B3.71B2.9B2.28B1.82B1.79B1.54B1.59B1.36B1.67B1.63B1.6B1.57B1.6B1.45B1.23B1.17B
Equity Growth %-11.81%0.71%9.95%5.66%12.72%9.87%39.28%-20.64%16.39%5.36%57.26%16.97%27.9%27.19%24.9%1.64%16.66%-3.01%16.57%-18.48%2.57%1.84%1.54%-1.63%10.39%18.11%4.52%-
Shareholders Equity10.2B13.37B13.28B12.07B11.43B10.12B9.2B6.61B8.32B7.09B6.7B4.2B3.4B2.61B2.05B1.6B1.77B1.5B1.55B1.36B1.41B1.37B1.34B1.31B1.33B1.18B977.6M942.3M
Minority Interest10.06M13.99M14M14M14M34M34M26.99M41M92M112M134M306.6M289M227.4M224.5M20.7M34.5M39.6M600K260.7M260.8M260.8M260.8M267.5M267.5M249.1M231.3M
Common Stock6.94B9.38B9.04B8.46B7.76B7.24B6.71B4.79B5.82B5.6B4.74B2.16B2.02B1.7B1.64B00001.36B1.41B1.37B1.34B1.31B1.33B1.18B977.6M942.3M
Additional Paid-in Capital62.55M85.93M84M82M81M79M79M60.15M84M76M75M28.8M8.8M4.1M2.8M3.3M3.7M3.6M3.4M1.07B1.06B1.04B1.02B1.01B1B845.4M680.8M676.5M
Retained Earnings1.4B1.61B1.47B1.8B1.58B1.35B1.5B904.57M1.07B891M1.08B1.17B1.01B817.2M788.1M735.9M651.4M589.9M530.6M499.6M450.9M423.4M399.6M365.3M328.9M330M296.8M265.8M
Accumulated OCI768.52M872.29M1.26B305M578M25M-79M73.26M338M-188M106M136.5M-347.6M-430.1M-775.8M-671.7M-164.7M-186.7M-69.2M-209M-100.2M-98.2M-82M-61.1M2.9M6M-1.25B-1.17B
Return on Assets (ROA)2.59%2.48%1.38%2.64%2.72%1.71%3.52%2.49%2.44%1.01%1.24%3.91%4.62%2.89%3.06%3.74%3.34%3.33%3.06%3.68%3.12%3.05%3.34%3.33%2.13%3.31%3.57%3.46%
Return on Equity (ROE)8.53%8.16%4.47%8.87%9.34%5.78%12.39%9.45%9.6%4.2%4.57%10.62%13.11%9.15%10.77%13.69%11.66%11.25%9.82%9.99%7.63%7.52%8.19%8.14%5.48%8.54%8.7%8.55%
Debt / Equity1.69x1.62x1.49x1.64x1.66x1.62x1.67x1.84x1.99x2.11x2.31x1.10x1.08x1.43x1.63x1.93x1.81x1.77x1.54x1.34x1.08x1.15x1.17x1.20x1.21x1.48x1.27x1.35x
Debt / Assets49.85%48.28%46.12%50.15%47.92%47.89%49.33%49.57%51.36%52.56%53.77%39.7%40.76%46.53%49.23%50.83%51.31%51.57%46.47%43.76%44.19%46.86%47.51%49.08%49.57%54.1%52.77%54.77%
Net Debt / EBITDA5.45x7.45x8.74x6.74x7.24x8.68x7.42x5.31x7.02x6.47x13.34x4.31x3.76x5.90x6.06x5.93x6.38x5.16x5.12x3.70x3.47x4.17x3.15x3.33x4.57x5.29x4.09x4.34x
Book Value per Share33.5744.6645.9944.1543.0339.437.2227.5835.7233.5439.6329.6925.2121.818.1814.4514.912.6812.710.9214.8614.6314.281416.2615.2214.0713.52

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Nova Scotia regulatory intervention

Rate Base Growth Outpaces Equity

According to recent financial statements, Emera's net PPE grew from $25.2B in 2024Q1 to $29.0B in 2026Q2, a 15% increase, while equity rose only 16% over the same period, indicating asset growth is largely debt-funded.

The sustained capital expenditure program, averaging over $800M per quarter, has expanded the rate base, but the corresponding equity growth has been modest, suggesting that the incremental assets are being financed with leverage. This pattern may indicate that the company is relying on debt to fund its growth, which could pressure future returns if regulatory approvals do not keep pace. Investors should monitor whether the expanding rate base eventually translates into higher authorized returns and earnings.

PPE Expansion Signals Regulatory Investment

As reported in financial statements, Emera's net PPE increased from $25.2B in 2024Q1 to $29.0B in 2026Q2, a 15% rise, reflecting continued investment in regulated assets, though the pace of growth appears to be decelerating in recent quarters.

The growth in net PPE is consistent with the company's strategy of investing in regulated infrastructure, particularly in Florida and Nova Scotia. However, the quarter-over-quarter changes show some volatility, with a notable jump in 2026Q1 followed by a slight decline in 2026Q2, which may reflect timing of asset additions or impairments. The sustained investment suggests a commitment to rate base expansion, but the regulatory recovery timeline remains a key variable, as any lag in rate case approvals could delay cash flows.

Leverage Creeps Higher Despite Asset Sales

Based on reported figures, Emera's debt-to-equity ratio rose from 1.49 in 2024Q4 to 1.54 in 2026Q2, while total debt increased by $2.3B, indicating that the company continues to rely on debt financing despite efforts to recycle assets.

The debt-to-equity ratio has remained elevated, hovering around 1.5x, which is above the typical authorized levels for utilities (often 50-60% debt to capital). This suggests that Emera may be operating with less headroom under its regulatory parameters, potentially limiting financial flexibility. The company's asset recycling strategy may be intended to manage this leverage, but the data shows that debt levels have not declined, indicating that the proceeds may be reinvested rather than used for deleveraging.

Equity Growth Lags Asset Expansion

According to financial data, Emera's equity increased from $12.4B in 2024Q1 to $14.4B in 2026Q2, a 16% rise, but this growth is outpaced by the 15% increase in net PPE, suggesting that retained earnings and equity issuance are not keeping up with capital needs.

The equity base has grown steadily, likely supported by retained earnings and occasional equity issuances, but the pace is insufficient to fund the aggressive capex program without additional debt. The return on equity has been volatile, with quarterly ROE ranging from 0.2% to 4.9%, indicating that earnings are not consistently translating into equity growth. This may reflect regulatory lag or the impact of non-cash items, and investors should monitor whether the company can maintain its dividend payout while funding growth.

Liquidity Tightens as Cash Reserves Fluctuate

As per recent balance sheet data, Emera's cash balance swung from $1.8B in 2026Q1 to $407M in 2026Q2, while the current ratio fell from 1.07 to 0.73, indicating a sharp deterioration in short-term liquidity.

The significant drop in cash and current ratio suggests that the company may have deployed cash for capital expenditures or debt repayment, but it also raises concerns about its ability to cover short-term obligations. The current ratio below 1.0 indicates that current liabilities exceed current assets, which is common for utilities but still warrants monitoring. The company likely relies on its revolving credit facilities and commercial paper programs to manage liquidity, but the tightness in 2026Q2 may indicate increased reliance on external financing.

Regulatory Disallowance Risk in Nova Scotia

The most significant balance sheet risk appears to be the potential for regulatory disallowances in Nova Scotia, where legislative intervention could impair the recovery of invested capital, as suggested by recent political actions.

Emera's Nova Scotia operations are subject to political and regulatory pressures that could lead to lower allowed returns or disallowed costs, which would directly impact the recoverability of its rate base. The company's balance sheet shows significant investment in Canadian assets, and any adverse regulatory decision could result in impairments or write-downs, reducing equity and increasing leverage. Investors should monitor the regulatory environment in Nova Scotia closely, as any negative development could undermine the company's financial stability.

EMA — Frequently Asked Questions

Quick answers to the most common questions about buying EMA stock.

What are the total assets of Emera Incorporated (EMA)?

As of 2025, Emera Incorporated (EMA) had total assets of $44.78B including $4.39B in current assets.

How much debt does Emera Incorporated (EMA) have?

Emera Incorporated (EMA) carries total debt of $21.62B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Emera Incorporated?

Emera Incorporated (EMA) has total shareholders' equity (book value) of $13.37B ($44.66 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Emera Incorporated's current ratio and liquidity?

Emera Incorporated (EMA) reported a current ratio of 0.66x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.